TMPRSS2-Coagulation Nexus: A Novel Molecular Link Revealed by Pairwise Correlation Analysis Following AstraZeneca (ChAdOx1 nCoV-19) Vaccination in a Nigerian Cohort
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
While haematological and coagulation changes following AstraZeneca vaccination have been described, the molecular mechanisms linking TMPRSS2 expression to coagulation remain underexplored, particularly in African populations.
Methods
In this case-control study, 102 adults (51 vaccinated with AstraZeneca ≥6 months prior, 51 unvaccinated controls) aged 18–65 years in Port Harcourt, Nigeria, were evaluated. Full blood count (Sysmex XN-1000), PT/aPTT (Erba Mannheim), RNA concentration, and qRT-PCR for ACE2/TMPRSS2 (normalized to GAPDH) were performed. Pearson correlations and t-tests were conducted (SPSS v26, p<0.05).
Results
Because primary between-group comparisons from this cohort have been reported previously, the present analysis focused on correlation patterns. A statistically significant inverse correlation was observed between TMPRSS2 Ct values and activated partial thromboplastin time (aPTT) among vaccinated participants (r = −0.325, p = 0.0202), whereas no corresponding association was detected in unvaccinated controls. Sex-specific differences in TMPRSS2 expression were also observed. No participant reported severe thrombotic or haemorrhagic complications at the time of recruitment.
Conclusion
This secondary analysis identified a statistically significant inverse correlation between TMPRSS2 Ct values and aPTT among AstraZeneca-vaccinated individuals. Although causality cannot be inferred, the findings suggest a potential relationship between TMPRSS2 expression and haemostatic pathways in the post-vaccination setting. Larger longitudinal studies are required to validate the observation and clarify its biological significance.
